TMO

Thermo Fisher Scientific

Health Care

Life Sciences Tools & Services

Waltham, Massachusetts

Last filing: Feb 26, 2026 (FY2025)

Account	2025	2024	2023	2022	2021
BS_Assets_Cash	$0	$4.0B	$8.1B	$8.5B	$4.5B
BS_Assets_AcctsReceivable	$0	$8.2B	$8.2B	$8.1B	$8.0B
BS_Assets_Inventory	$0	$5.0B	$5.1B	$5.6B	$5.1B
BS_Assets_PPE	$0	$9.3B	$9.4B	$9.3B	$8.3B
BS_Assets_Goodwill	$2.1B	$45.9B	$44.0B	$41.2B	$41.9B
BS_Assets_IntangibleAssets	$0	$15.5B	$16.7B	$17.4B	$20.1B
BS_Liab_AccruedLiab	$0	$2.0B	$1.6B	$2.1B	$2.4B
BS_Liab_LongTermDebt	$0	$31.1B	$34.7B	$34.3B	$34.7B
BS_Liab_OtherNoncurrent	$0	$4.0B	$4.6B	$4.2B	$4.5B
BS_Equity_PreferredStock	$0	$50.1K	$50.1K	$50.1K	$50.1K
BS_Equity_CommonStock	$0	$444.0M	$442.0M	$441.0M	$439.0M
BS_Equity_TreasuryStock	$3.0B	$19.2B	$15.1B	$12.0B	$8.9B
BS_Equity_AOCI	$0	$-2.7B	$-3.2B	$-3.1B	$-2.3B

Account	2025	2024	2023	2022	2021
IS_Revenue_Total	$44.6B	$42.9B	$42.9B	$44.9B	$39.2B
IS_Expense_COGS	$36.8B	$35.5B	$36.0B	$36.5B	$29.2B
IS_Expense_RnD	$1.4B	$1.4B	$1.3B	$1.5B	$1.4B
IS_Expense_SGA	$8.7B	$8.6B	$8.4B	$9.0B	$8.0B
IS_Expense_DA	$1.7B	$2.0B	$2.3B	$2.4B	$1.8B
IS_Expense_SBC	$310.0M	$301.0M	$278.0M	$307.0M	$230.0M
IS_Expense_Restructuring	$197.0M	$97.0M	$194.0M	$68.0M	$37.0M
IS_Expense_TotalOpex	$36.8B	$35.5B	$36.0B	$36.5B	$29.2B
IS_OperatingIncome	$7.7B	$7.3B	$6.9B	$8.4B	$10.0B
IS_InterestIncome	$993.0M	$1.1B	$879.0M	$272.0M	$43.0M
IS_InterestExpense	$1.4B	$1.4B	$1.4B	$726.0M	$536.0M
IS_OtherNonopIncExp	$-12.0M	$12.0M	$-65.0M	$-104.0M	$-694.0M
IS_PreTaxIncome	$7.3B	$7.0B	$6.3B	$7.8B	$8.8B
IS_TaxExpense	$547.0M	$657.0M	$284.0M	$703.0M	$1.1B
IS_NetIncome	$6.7B	$6.3B	$6.0B	$7.0B	$7.7B
IS_ComprehensiveIncome	$7.0B	$6.9B	$5.9B	$6.2B	$8.2B
IS_EPS_Basic	$18	$17	$16	$18	$20
IS_EPS_Diluted	$18	$17	$15	$18	$19
IS_Shares_Basic	$377.0M	$382.0M	$386.0M	$392.0M	$394.0M
IS_Shares_Diluted	$378.0M	$383.0M	$388.0M	$394.0M	$397.0M

Account	2025	2024	2023	2022	2021
CF_Ops_NetIncome	$6.7B	$6.3B	$6.0B	$7.0B	$7.7B
CF_Ops_DA	$1.1B	$1.2B	$1.1B	$986.0M	$831.0M
CF_Ops_SBC	$310.0M	$301.0M	$278.0M	$307.0M	$230.0M
CF_Ops_DeferredTax	$-639.0M	$-1.2B	$-1.3B	$-997.0M	$-645.0M
CF_Ops_WorkingCapital	$921.0M	$410.0M	$-1.1B	$1.9B	$1.7B
CF_Ops_NetCash	$7.8B	$8.7B	$8.4B	$9.2B	$9.3B
CF_Inv_Capex	$1.5B	$1.4B	$1.5B	$2.2B	$2.5B
CF_Inv_Acquisitions	$4.0B	$3.1B	$3.7B	$39.0M	$19.4B
CF_Inv_PurchaseInvestments	$383.0M	$3.4B	$208.0M	$52.0M	—
CF_Inv_Other	$-21.0M	$-8.0M	$-33.0M	$-20.0M	$42.0M
CF_Inv_NetCash	$-4.0B	$-5.8B	$-5.1B	$-2.2B	$-21.9B
CF_Fin_DebtIssuance	$7.8B	$1.2B	$5.9B	$3.2B	$18.1B
CF_Fin_DebtRepayment	$2.4B	$3.6B	$5.8B	$375.0M	$11.7B
CF_Fin_ShareRepurchases	$3.0B	$4.0B	$3.0B	$3.0B	$2.0B
CF_Fin_Dividends	$636.0M	$583.0M	$523.0M	$455.0M	$395.0M
CF_Fin_Other	$90.0M	$195.0M	$56.0M	$-9.0M	$65.0M
CF_Fin_NetCash	$1.8B	$-6.8B	$-3.6B	$-2.8B	$6.6B
CF_Net_Change	$5.8B	$-4.1B	$-440.0M	$4.0B	$-5.8B

Stock price history for TMO hasn't been loaded yet.